What is Zacks Research’s Forecast for Itron Q1 Earnings?

Itron, Inc. (NASDAQ:ITRI) – Equities researchers at Zacks Research lowered their Q1 2027 earnings per share (EPS) estimates for Itron in a research report issued on Tuesday, March 10th. Zacks Research analyst Team now anticipates that the scientific and technical instruments company will post earnings per share of $1.37 for the quarter, down from their prior forecast of $1.67. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Itron’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Itron’s Q3 2027 earnings at $1.90 EPS.

Several other research analysts have also weighed in on ITRI. Oppenheimer increased their price objective on shares of Itron from $125.00 to $133.00 and gave the stock an “outperform” rating in a report on Wednesday, February 18th. Wall Street Zen downgraded shares of Itron from a “buy” rating to a “hold” rating in a research note on Wednesday, January 14th. Robert W. Baird set a $128.00 price target on shares of Itron and gave the company an “outperform” rating in a report on Wednesday, February 18th. Weiss Ratings downgraded Itron from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Finally, Needham & Company LLC started coverage on Itron in a report on Friday, March 6th. They issued a “buy” rating and a $124.00 target price on the stock. Eight equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $137.10.

Itron Stock Down 1.5%

Shares of NASDAQ:ITRI opened at $90.62 on Thursday. The company has a current ratio of 1.80, a quick ratio of 1.56 and a debt-to-equity ratio of 0.45. The firm has a market cap of $4.07 billion, a price-to-earnings ratio of 13.92, a PEG ratio of 0.80 and a beta of 1.44. The stock’s 50-day moving average price is $97.42 and its two-hundred day moving average price is $107.07. Itron has a 12-month low of $88.57 and a 12-month high of $142.00.

Itron (NASDAQ:ITRI) last posted its quarterly earnings data on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.19 by $0.27. The business had revenue of $571.66 million for the quarter, compared to analysts’ expectations of $561.31 million. Itron had a return on equity of 20.04% and a net margin of 12.72%.The business’s revenue was down 6.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.35 earnings per share. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS.

Institutional Trading of Itron

Several large investors have recently bought and sold shares of ITRI. Twin Peaks Wealth Advisors LLC acquired a new position in Itron in the 2nd quarter worth $30,000. Employees Retirement System of Texas acquired a new position in shares of Itron in the third quarter worth about $32,000. Private Trust Co. NA boosted its holdings in Itron by 112.4% in the fourth quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock valued at $25,000 after purchasing an additional 145 shares during the last quarter. Optiver Holding B.V. acquired a new stake in Itron during the 3rd quarter valued at approximately $36,000. Finally, Salomon & Ludwin LLC acquired a new position in shares of Itron in the 3rd quarter valued at approximately $42,000. Institutional investors and hedge funds own 96.19% of the company’s stock.

Insider Buying and Selling at Itron

In related news, SVP Justin K. Patrick sold 4,930 shares of the company’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $99.54, for a total transaction of $490,732.20. Following the completion of the sale, the senior vice president directly owned 34,344 shares of the company’s stock, valued at approximately $3,418,601.76. This represents a 12.55% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP John F. Marcolini sold 6,948 shares of the stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $99.54, for a total value of $691,603.92. Following the completion of the sale, the senior vice president owned 26,912 shares of the company’s stock, valued at approximately $2,678,820.48. This represents a 20.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 51,180 shares of company stock worth $5,085,475. Corporate insiders own 1.45% of the company’s stock.

Itron News Roundup

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Zacks raised Q2 2027 EPS to $1.71 (from $1.66) and nudged Q3 2027 estimates to $1.90, suggesting stronger mid‑term earnings momentum that may support the stock if trends continue.
• Positive Sentiment: Zacks lifted Q4 2026 EPS to $1.73 (from $1.49) and issued an optimistic FY2028 projection of $8.86, indicating upside potential farther out that could attract longer‑term investors.
• Neutral Sentiment: Zacks kept a “Hold” rating and left the consensus full‑year EPS baseline near $5.33 — the report is a recalibration of estimates rather than a change in analyst conviction.
• Neutral Sentiment: The revisions are mixed across quarters (some raises, some cuts), so near-term volatility is likely while investors digest timing and magnitude of the changes.
• Negative Sentiment: Zacks cut Q1 2027 EPS sharply to $1.37 from $1.67, a sizeable downgrade that likely drove immediate downside as it reduces near‑term earnings visibility.
• Negative Sentiment: Multiple downward tweaks to Q1/Q2 2026, Q3 2026 and FY2026 estimates (FY2026 trimmed to $5.98) and a FY2027 cut to $6.72 from $6.95 point to weaker near‑term fundamentals and weigh on sentiment.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.